These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 10359383)

  • 1. Screening for type 2 diabetes.
    Kessel E
    JAMA; 1999 Jun; 281(21):1987-8. PubMed ID: 10359383
    [No Abstract]   [Full Text] [Related]  

  • 2. Finding undiagnosed type 2 diabetes: is it worth the effort?
    Engelgau MM; Narayan KM
    Eff Clin Pract; 2001; 4(6):281-3. PubMed ID: 11769302
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for type 2 diabetes.
    Goyder E; Irwig L
    JAMA; 1999 Jun; 281(21):1986-7; author reply 1987-8. PubMed ID: 10359382
    [No Abstract]   [Full Text] [Related]  

  • 4. [Opportunistic screening for diabetes in primary health care. Life style changes can prevent diabetes mellitus among individuals at risk].
    Hagström B
    Lakartidningen; 2002 Apr; 99(16):1852. PubMed ID: 12043490
    [No Abstract]   [Full Text] [Related]  

  • 5. [Screening and intervention. A strategy in type 2 diabetes?].
    Jørgensen T; Glümer C; Borch-Johnsen K
    Ugeskr Laeger; 2002 Apr; 164(16):2135-9. PubMed ID: 11989055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the price of life and why doesn't it increase at the rate of inflation?
    Ubel PA; Hirth RA; Chernew ME; Fendrick AM
    Arch Intern Med; 2003 Jul; 163(14):1637-41. PubMed ID: 12885677
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost effectiveness of preventive screening programmes for type 2 diabetes mellitus in Germany.
    Schaufler TM; Wolff M
    Appl Health Econ Health Policy; 2010; 8(3):191-202. PubMed ID: 20408603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using an economic model of diabetes to evaluate prevention and care strategies in Australia.
    Colagiuri S; Walker AE
    Health Aff (Millwood); 2008; 27(1):256-68. PubMed ID: 18180502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we screen for type 2 diabetes: Yes.
    Khunti K; Davies M
    BMJ; 2012 Jul; 345():e4514. PubMed ID: 22777029
    [No Abstract]   [Full Text] [Related]  

  • 10. A cost analysis of community screening for diabetes in the central Wisconsin Medicare population (results from the MetaStar pilot project in Wausau).
    Lee DS; Remington P; Madagame J; Blustein J
    WMJ; 2000 Jun; 99(3):39-43. PubMed ID: 10927980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost of screening for diabetes and intermediate hyperglycaemia.
    Colagiuri S
    Diabetes Res Clin Pract; 2012 Sep; 97(3):341-2. PubMed ID: 22682947
    [No Abstract]   [Full Text] [Related]  

  • 12. Opportunistic screening for diabetes.
    Easton JL; Segal L
    Med J Aust; 1998 Jan; 168(1):45. PubMed ID: 9451399
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost effectiveness of screening of all newly recruited employees for diabetes at a tertiary care hospital.
    Ali NS; Khuwaja AK
    J Ayub Med Coll Abbottabad; 2007; 19(2):23-5. PubMed ID: 18183713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of type 2 diabetes screening: results from recently published studies.
    Icks A; Rathmann W; Haastert B; John J; Löwel H; Holle R; Giani G;
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S167-71. PubMed ID: 16032536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for diabetes in general practice. Population screening for diabetes is cost effective.
    Higson N
    BMJ; 2002 Feb; 324(7334):426. PubMed ID: 11855395
    [No Abstract]   [Full Text] [Related]  

  • 16. The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel.
    Marseille E; Lohse N; Jiwani A; Hod M; Seshiah V; Yajnik CS; Arora GP; Balaji V; Henriksen O; Lieberman N; Chen R; Damm P; Metzger BE; Kahn JG
    J Matern Fetal Neonatal Med; 2013 May; 26(8):802-10. PubMed ID: 23311860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for diabetes.
    Backholer K; Chen L; Shaw J
    Pathology; 2012 Feb; 44(2):110-4. PubMed ID: 22228253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economics of type 2 diabetes prevention.
    Kissimova-Skarbek K
    Przegl Lek; 2006; 63 Suppl 4():9-11. PubMed ID: 16967708
    [No Abstract]   [Full Text] [Related]  

  • 19. Maximizing efficiency and cost-effectiveness of Type 2 diabetes screening: the AusDiab study.
    Chen L; Magliano DJ; Balkau B; Wolfe R; Brown L; Tonkin AM; Zimmet PZ; Shaw JE
    Diabet Med; 2011 Apr; 28(4):414-23. PubMed ID: 21392062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential savings in Mexico from screening and prevention for early diabetes and hypertension.
    Castro-Ríos A; Doubova SV; Martínez-Valverde S; Coria-Soto I; Perez-Cuevas R
    Health Aff (Millwood); 2010 Dec; 29(12):2171-9. PubMed ID: 21134917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.